Menu icon
A vertical stack of three evenly spaced horizontal lines.
Business Insider logo
Markets Insider logo
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
My Watchlist
Markets
Stocks
Indices
Commodities
Cryptocurrencies
Currencies
ETFs
News
Calendar icon
An icon in the shape of a calendar.
Economic
Earnings
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Markets Insider logo
Close icon
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
Markets
Bonds
Funds
Pre-Market
Market Movers
Dow Jones Live
Your Portfolio
Stocks
Stocks Finder
Market Movers
Index Constituents
Earnings Calendar
Dividends
Indices
Market Movers
Index Constituents
Dow Jones Live
S&P 500 Live
Nasdaq Live
World Map
Commodities
News
Commodities Live
Gold
Oil
Copper
Cryptocurrencies
Bitcoin
Ethereum
Cryptocurrencies Live
Currencies
News
Currencies Live
Currency Converter
EUR/USD
GBP/USD
US Dollar Index
ETFs
News
ETF Finder
ETF Issuers
News
My Watchlist
My Watchlist
Facebook Icon
The letter F.
Twitter icon
A stylized bird with an open mouth, tweeting.
LinkedIn icon
YouTube icon
A play button in the shape of a television screen.
Instagram icon
A stylized camera.
Business Insider logo
© 2024
Insider Inc. and
finanzen.net
GmbH (Imprint). All rights reserved.
Registration on or use of this site constitutes acceptance of our
Terms of Service
and
Privacy Policy.
Disclaimer
Accessibility
Commerce Policy
Advertising Policies
Stock quotes by
finanzen.net
Home
News
News for Merck Co.
Seeking Alpha
88d
HOOKIPA stock falls 20% in wake of Phase 1/2 study results
Seeking Alpha
88d
CG Oncology climbs 10% on Phase 2 data for bladder cancer drug
Seeking Alpha
88d
Merck, Kelun buoyed by phase 3 results for breast cancer antibody drug conjugate
Seeking Alpha
88d
Merus rallies on publication of oncology study abstracts
Seeking Alpha
88d
Merck HPV vaccine associated with lower head and neck cancer rates in men
InvestorPlace
88d
Bargain Bin: 3 Cheap Stocks to Buy Before Memorial Day
TipRanks
90d
Wells Fargo Sticks to Their Hold Rating for Merck & Company (MRK)
Seeking Alpha
93d
SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?
Seeking Alpha
94d
Novo Nordisk, J&J lead R&D rankings in big pharma: report
Seeking Alpha
95d
Dow at 40K: Leaders and laggards over the last 10,000 points
InvestorPlace
95d
Storm Shelter: 7 Safe Haven Stocks to Batten Down the Hatches
TipRanks
96d
Bank of America Securities Keeps Their Buy Rating on Merck & Company (MRK)
Seeking Alpha
97d
Short interest in S&P 500 healthcare sector dips in April, biotechnology companies most shorted
Benzinga
97d
Merck Ends Keytruda Combo Melanoma Study Due to Futility
Seeking Alpha
98d
Health care is still very crowded but trades at a discount vs. history - BofA
TipRanks
98d
Analysts Are Bullish on Top Healthcare Stocks: Merck & Company (MRK), Inovio Pharmaceuticals (INO)
RTTNews
99d
Merck Discontinues Vibostolimab And Pembrolizumab Coformulation Arm Of Phase 3 Trial In Melanoma
Seeking Alpha
99d
Merck discontinues testing of experimental skin cancer combo therapy
InvestorPlace
102d
3 Biotech Stocks to Sell in May Before They Crash & Burn
InvestorPlace
102d
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
Benzinga
103d
A Look at Pharma ETFs Post Q1 Earnings
RTTNews
103d
Merck's Phase 3 Trial Of KEYTRUDA Plus Chemotherapy In Endometrial Cancer Fails To Meet Primary Goal
InvestorPlace
103d
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
RTTNews
103d
Merck' Keytruda Receives Approval From Health Canada For Biliary Tract Carcinoma In Adults
Seeking Alpha
103d
Merck says Keytruda failed as first-line therapy for uterine cancer
Seeking Alpha
104d
CytomX teams up with Merck for CX-801 clinical study
InvestorPlace
106d
3 Biotech Stocks to Double Your Money in the Next 24 Months
Seeking Alpha
106d
Calliditas releases phase 2 results on head and neck cancer asset setanaxib
Seeking Alpha
108d
Pharma R&D productivity seen improving for the first time in years - Deloitte
Benzinga
109d
Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected (UPDATED)
Seeking Alpha
109d
Janux Therapeutics gains amid renewed takeover speculation
Seeking Alpha
110d
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha
111d
Merck Keytruda combo meets main goal in late-stage trial for advanced gastric cancer
TipRanks
112d
Buy Rating Affirmed on Merck & Company Following Strong Q1 Performance and Upbeat Full-Year Guidance
Seeking Alpha
113d
Merck late-stage data strengthens profile of pneumonia vaccine candidate
Seeking Alpha
116d
19 out 20 S&P 500 healthcare companies beat profit estimates - Earnings Scorecard
TipRanks
116d
Merck & Company: A Strong Buy on Robust Performance and Future Growth Prospects
TipRanks
116d
Merck & Co. Outperforms with Strong Keytruda Sales and Raised Guidance: A Buy Rating Affirmed
TipRanks
116d
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Globus Medical (GMED) and Merck & Company (MRK)
TipRanks
116d
Merck & Company (MRK) Gets a Buy from Barclays
Benzinga
117d
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
InvestorPlace
117d
MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q1 2024
RTTNews
117d
Merck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-market
Seeking Alpha
117d
Bristol-Myers posts Q1 beat despite growth headwinds
Seeking Alpha
117d
Merck raises guidance as Keytruda sales jump 20% in Q1
Seeking Alpha
117d
Merck in charts: Pharmaceutical segment soars on KEYTRUDA, GARDASIL strength in Q1
Seeking Alpha
117d
Merck Non-GAAP EPS of $2.07 beats by $0.15, revenue of $15.8B beats by $600M
TipRanks
117d
Analysts Conflicted on These Healthcare Names: Travere Therapeutics (TVTX), Humana (HUM) and Merck & Company (MRK)
Seeking Alpha
117d
Immutep reports promising efti/Keytruda data for head and neck cancer
Markets Insider Automation
118d
Merck earnings: here's what Wall Street expects
Page
Page
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
Page
Merck Peer Group News
12/11/20
Pfizer falls 2% as FDA nears final authorization of its COVID-19 vaccine
12/01/20
S&P 500 and Nasdaq close at record highs as investors bet that a vaccine will drive an economic rebound
11/18/20
Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval
11/09/20
Gold slides the most in 3 months as encouraging vaccine data boosts risk appetites
09/21/20
Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare
08/19/20
Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover
07/13/20
Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)
07/01/20
Pfizer leaps 6% after releasing positive trial results for coronavirus vaccine
Find News
News
GO